Professor Gareth Evans, Cancer Lead for the Manchester Biomedical Research Centre (BRC) outlines why this NIHR funding is so important to being able to deliver a personalised approach to disease treatment and prevention.
New test set to transform breast cancer prevention Women who have a family history of breast cancer are set to benefit from a new genetic test at Manchester University NHS Foundation Trust (MFT) that assesses breast cancer risk
The NIHR Manchester BRC, in collaboration with the NIHR Manchester CRF and supported by Oxford Road Corridor and Health Innovation Manchester is investing in the next generation of NHS researchers and want you to be part of it.
This workshop will provide attendees with opportunities to discuss and develop practical strategies for effective PPIE to enhance the design and delivery of their research and to meet the requirements of research funders.
Three new publications in the high impact JAMA group of journals provide information that could shape the way in which patients with a genetic predisposition are screened for cancers associated with brain and nerve cell tumours, Lynch Syndrome and Li-Fraumeni Syndrome.
The BRC has been busy this summer conducting scoping work to inform an ambitious, five year patient and public involvement and engagement (PPIE) strategy. Delivering exemplary PPIE across Greater Manchester, the strategy will serve both the BRC and the NIHR Manchester CRF.
The NIHR Manchester BRC and CRF launch event on 6 June 2017 represented a double celebration. An opportunity to share our aspirations for BRC and CRF, and also to mark the first anniversary of the GMHSCP devolution of the city region’s £6bn health and social care budget.
The Public Programmes Team, which leads on PPIE within the BRC and CRF, has secured a five year award from the Wellcome Trust Sustaining Excellence grant scheme following a rigorous and by invitation only review process.